Drugs Made In America Acquisition Corp. (DMAA) Stock

Financial Services · Shell Companies · Member of Other US Stocks

Drugs Made In America Acquisition Corp. (DMAA) closed at USD 10.86 on 2026-10-14, a change of +5.3 % over the past year, with a market capitalization of USD 263.89M.

Drugs Made In America Acquisition Corp. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Drugs Made In America Acquisition Corp. key figures

Previous close

USD 10.86 (2026-10-14)

1-year change

+5.3 %

Market cap

USD 263.89M

Enterprise value

USD 264.22M

P/E ratio (trailing)

60.39

P/E ratio (forward)

n/a

EPS (trailing)

0.18

EPS (forward)

n/a

PEG ratio

n/a

Price to book

-35.64

Revenue growth

n/a

Earnings growth

-17.9 %

Dividend per share (trailing)

0.00

Short ratio

2.43

Employees

n/a

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Drugs Made In America Acquisition Corp.

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Drugs Made In America Acquisition Corp. and compare it with other stocks.